ALLERGIC RHINITIS IN CHILDREN AND ADOLESCENTS AGED 5–17 YEARS: KEY LINKS IN THE ATOPIC MARCH, CLINICAL AND DIAGNOSTIC FEATURES, AND MANAGEMENT STRATEGIES
DOI:
https://doi.org/10.11603/24116-4944.2025.1.15409Keywords:
allergic rhinitis, pediatric allergy, comorbidity, bronchial asthma, atopic dermatitis, allergic conjunctivitis, urban environment, genetic predisposition, ARIA protocol, symptom severity, seasonal variation, intranasal corticosteroids, antihistamines, combination therapy, quality of life, psycho-emotional impact, sleep disturbances, nasal obstruction, Visual Analogue Scale (VAS), allergic multimorbidity, environmental factors, pediatric outpatient studyAbstract
The aim of the study – a comprehensive study of allergic rhinitis as one of the key stages of the atopic march in children and adolescents aged 5 to 17 years based on the analysis of clinical data of patients included in our own research.
Materials and Methods. This study was conducted from January to April 2025 in a pediatric outpatient setting involved 198 children, of whom 42 aged 5–17 years had allergic rhinitis (AR) symptoms. Participants were categorized by age, gender, social-territorial factors, and clinical features for comprehensive analysis. The middle age group (10–13 years) accounted for the highest prevalence (40.5 %), indicating age-related susceptibility. Boys slightly predominated (55 %), consistent with global trends in early allergic disease development. Seasonal analysis revealed 60 % of cases during winter, likely due to viral infections exacerbating AR, and 40 % in spring, correlating with pollen exposure. Urban residence predominated (75 %), reflecting environmental risk factors like pollution. Genetic predisposition was significant, with 65 % having a family history of allergic diseases, associated with more severe and prolonged symptoms. Comorbidities were frequent: bronchial asthma (28 %), allergic conjunctivitis (32 %), atopic dermatitis (4.7 %), otitis media (18 %), sinusitis (12 %), and adenoiditis (10 %), highlighting the allergic multimorbidity concept. Clinical symptoms included serous rhinorrhea (90 %), sneezing (81.6 %), nasal itching (75 %), obstruction (70 %), and ophthalmic symptoms (58.3 %), reflecting the classical AR presentation. The ARIA (AR and its Impact on Asthma) protocol enabled effective diagnosis and stratification: 65 % had persistent rhinitis, 35 % intermittent.
Results and Discussion. Treatment response to intranasal corticosteroids and antihistamines was positive in 85 % within 5–7 days, supporting trial therapy’s diagnostic role. Combined therapy (antihistamines plus corticosteroids) showed superior efficacy, improving quality of life by 85 % versus 65 % and 48 % in monotherapy groups. Psycho-emotional impact was significant, with sleep disturbances, attention deficits, anxiety, and depressive symptoms noted, adversely affecting academic and social functioning. Oxygen saturation monitoring revealed mild nocturnal hypoxia in 22 %, linking nasal obstruction to impaired ventilation.
Conclusions. The study underscores the need for early diagnosis, personalized management, and comprehensive care addressing comorbidities and psychosocial effects in pediatric AR, especially in urban environments with genetic and environmental risk factors.
References
Bousquet, J., Hellings, P.W., Agache, I., Bedbrook, A., Bachert, C., Bergmann, K., ... & Sheikh, A. (2016). ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clinical and Translational Allergy, 6, 47. DOI: 10.1186/s13601-016-0137-4. DOI: https://doi.org/10.1186/s13601-016-0137-4
Bousquet, J., Van Cauwenberge, P., & Khaltaev, N. (2001). Allergic rhinitis and its impact on asthma. Journal of Allergy and Clinical Immunology, 108(5 Suppl), S147-S334. DOI: https://doi.org/10.1067/mai.2001.118891
Shekelle, P.G., Woolf, S.H., Eccles, M., & Grimshaw, J. (1999). Clinical guidelines: Developing guidelines. BMJ, 318(7183), 593-596. DOI: https://doi.org/10.1136/bmj.318.7183.593
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A., et al. (2008). Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA²LEN and AllerGen). Allergy, 63(Suppl 86), 8-160. DOI: https://doi.org/10.1111/j.1398-9995.2007.01620.x
Yang, L., Fu, J., & Zhou, Y. (2020). Research Progress in Atopic March. Frontiers in immunology, 11, 1907. DOI: 10.3389/fimmu.2020.01907. DOI: https://doi.org/10.3389/fimmu.2020.01907
Mrkić Kobal, I., Plavec, D., Vlašić Lončarić, Ž., Jerković, I., & Turkalj, M. (2023). Atopic March or Atopic Multimorbidity-Overview of Current Research. Medicina (Kaunas, Lithuania), 60(1), 21. DOI: 10.3390/medicina60010021. DOI: https://doi.org/10.3390/medicina60010021
Tsuge, M., Ikeda, M., Matsumoto, N., Yorifuji, T., & Tsukahara, H. (2021). Current Insights into Atopic March. Children (Basel, Switzerland), 8(11), 1067. DOI: 10.3390/children8111067. DOI: https://doi.org/10.3390/children8111067
Siddiqui, Z.A., Walker, A., Pirwani, M.M., Tahiri, M., & Syed, I. (2022). Allergic rhinitis: diagnosis and management. British journal of hospital medicine (London, England : 2005), 83(2), 1-9. DOI: 10.12968/hmed.2021.0570. DOI: https://doi.org/10.12968/hmed.2021.0570
Chirakalwasan, N., & Ruxrungtham, K. (2014). The linkage of allergic rhinitis and obstructive sleep apnea. Asian Pacific journal of allergy and immunology, 32(4), 276-286.
Ponda, P., Carr, T., Rank, M.A., & Bousquet, J. (2023). Nonallergic Rhinitis, Allergic Rhinitis, and Immunotherapy: Advances in the Last Decade. The journal of allergy and clinical immunology. In practice, 11(1), 35-42. DOI: 10.1016/j.jaip.2022.09.010. DOI: https://doi.org/10.1016/j.jaip.2022.09.010
Jáuregui, I., Mullol, J., Dávila, I., Ferrer, M., Bartra, J., del Cuvillo, A., ... & Valero, A. (2009). Allergic rhinitis and school performance. J Investig Allergol Clin Immunol., 19 (Suppl 1), 32-9. PMID: 19476052.
Mir, E., Panjabi, Ch., & Shah, A. (2024). Impact of allergic rhinitis in school going children. ResearchGate PDF. DOI: 10.5415/apallergy.2012.2.2.93. DOI: https://doi.org/10.5415/apallergy.2012.2.2.93
Greiner, A.N., Hellings, P.W., Rotiroti, G., Scadding, G. (2011). Allergic rhinitis. Lancet, 378(9809), 2112-2122. DOI: 10.1016/S0140-6736(11)60159-0. DOI: https://doi.org/10.1016/S0140-6736(11)60130-X
Bousquet, J., Annesi-Maesano, I., Carat, F., Léger, D., Rugina, M., Pribil, C., ... & Chanal, I. (2005). Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 35(6), 728-732. DOI: 10.1111/j.1365-2222.2005.02274.x. DOI: https://doi.org/10.1111/j.1365-2222.2005.02274.x
Brozek, J.L., Akl, E.A., Alonso-Coello, P., Lang, D., Jaeschke, R., Williams, J.W., ... & Schünemann, H.J. (2009). GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy, 64(5), 669-677. DOI: 10.1111/j.1398-9995.2009.01973.x. DOI: https://doi.org/10.1111/j.1398-9995.2009.01973.x
Brozek, J.L., Baena-Cagnani, C.E., Bonini, S., Canonica, G.W., Rasi, G., van Wijk, R.G., ... & Schünemann, H.J. (2008). Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy, 63(1), 38-46. DOI: 10.1111/j.1398-9995.2007.01560.x. DOI: https://doi.org/10.1111/j.1398-9995.2007.01560.x
Brozek, J.L., Bousquet, J., Baena-Cagnani, C.E., Bonini, S., Canonica, G.W., Casale, T.B., ... & Schünemann, H.J. (2010). Global Allergy and Asthma European Network, Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. The Journal of Allergy and Clinical Immunology, 126(3), 466-476. DOI: 10.1016/j.jaci.2010.06.047. DOI: https://doi.org/10.1016/j.jaci.2010.06.047
Padjas, A., Kehar, R., Aleem, S., Mejza, F., Bousquet, J., Schünemann, H.J., ... & Brożek, J.L. (2014). Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study The Journal of Allergy and Clinical Immunology, 133(3), 777-783. e4. DOI: 10.1016/j.jaci.2013.08.029. DOI: https://doi.org/10.1016/j.jaci.2013.08.029
Wallace, D.V., Dykewicz, M.S., Bernstein, D.I., Blessing-Moore, J., Cox, L., Khan, D. A., ... & Tilles, S.A. (2008). Joint Task Force on Practice, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. The Journal of Allergy and Clinical Immunology, 122(Suppl 2), S1-S84. DOI: 10.1016/j.jaci.2008.06.003. DOI: https://doi.org/10.1016/j.jaci.2008.06.003
Karafilidis, J.G., & Andrews, W.T. (2008). Allergic rhinitis practice parameter update: correction to information regarding OMNARIS (ciclesonide) nasal spray. The Journal of allergy and clinical immunology, 122(6), 1236. DOI: 10.1016/j.jaci.2008.10.010 (accessed: 25 May 2025). DOI: https://doi.org/10.1016/j.jaci.2008.10.010
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Я. Д. Бондаренко, Д. Є. Кулик, М. К. Бірюкова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
